Jürgen Eberle

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Akos Heinemann

Professor

Medical University of Graz

AUSTRIA

View details

Michael Muehlebach

Section Head

Paul-Ehrlich-Institut

GERMANY

View details

Mathias Felix Leber

University of Ottawa

CANADA

View details

Gerald Hoefler

Professor for Pathology

Medical University of Graz

AUSTRIA

View details

Martin Pichler

Medical University of Graz

AUSTRIA

View details

Christine E. Engeland

Professor of Experimental Virology

Witten/Herdecke University

GERMANY

View details

Kamran Ghoreschi

Director/Prof.Dr.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Tobias Sinnberg

University of Tuebingen

GERMANY

View details

Bernhard Gillissen

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jürgen Eberle

Research Interests

Explore related searches

Contact this professor

Articles (13)

Correction: Sumarni et al. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP. <i>Cells</i> 2021, <i>10</i>, 987

Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x<sub>L</sub>/Bcl-w Inhibitors

Correction: Hazzan et al. Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-x<sub>L</sub>. <i>Cells</i> 2019, <i>8</i>, 829

Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins

Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro

Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far-UVC sources to minimise mycoses in clinical practice.

Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression

Inhibition of Cell Proliferation and Cell Viability by Sinecatechins in Cutaneous SCC Cells Is Related to an Imbalance of ROS and Loss of Mitochondrial Membrane Potential

Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies

Crucial Role of Reactive Oxygen Species (ROS) for the Proapoptotic Effects of Indirubin Derivatives in Cutaneous SCC Cells

Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP

High ROS Production by Celecoxib and Enhanced Sensitivity for Death Ligand-Induced Apoptosis in Cutaneous SCC Cell Lines

Ambivalent Effects of Tumor Necrosis Factor Alpha on Apoptosis of Malignant and Normal Human Keratinocytes.

Collaborators (9)

Akos Heinemann

Michael Muehlebach

Mathias Felix Leber

Gerald Hoefler

Martin Pichler

Christine E. Engeland

Kamran Ghoreschi

Tobias Sinnberg

Bernhard Gillissen

Make your next move.